- Home
- YSXT vs ALGS Comparison
YSXT vs ALGS Comparison
Compare YSXT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSXT | ALGS |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | China | United States |
| Employees | 39 | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 39.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | YSXT | ALGS |
|---|---|---|
| Price | $1.06 | $5.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 43.3K | ★ 122.6K |
| Earning Date | 02-03-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,186,000.00 |
| Revenue This Year | N/A | $32.20 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | $5.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.93 | $5.12 |
| 52 Week High | $9.90 | $13.69 |
Technical Indicators
Market Signals| Indicator | YSXT | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 42.09 |
| Support Level | $0.93 | N/A |
| Resistance Level | $1.31 | $6.82 |
| Average True Range (ATR) | 0.06 | 0.50 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 33.96 | 32.65 |
Price Performance
Historical ComparisonAbout YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.